Brian Gloss
Brian Gloss
Westmead Research Hub
Verified email at sydney.edu.au
Title
Cited by
Cited by
Year
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo
MC Milone, JD Fish, C Carpenito, RG Carroll, GK Binder, D Teachey, ...
Molecular therapy 17 (8), 1453-1464, 2009
10152009
lncRNAdb v2. 0: expanding the reference database for functional long noncoding RNAs
XC Quek, DW Thomson, JLV Maag, N Bartonicek, B Signal, MB Clark, ...
Nucleic acids research 43 (D1), D168-D173, 2015
4512015
The specificity of long noncoding RNA expression
BS Gloss, ME Dinger
Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1859 (1), 16-22, 2016
1352016
Unexpected features of the dark proteome
N Perdig„o, J Heinrich, C Stolte, KS Sabir, MJ Buckley, B Tabor, B Signal, ...
Proceedings of the National Academy of Sciences 112 (52), 15898-15903, 2015
1062015
Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer
C Montavon, BS Gloss, K Warton, CA Barton, AL Statham, JP Scurry, ...
Gynecologic oncology 124 (3), 582-588, 2012
942012
Epigenetic biomarkers in epithelial ovarian cancer
BS Gloss, G Samimi
Cancer letters 342 (2), 257-263, 2014
892014
Computational approaches for functional prediction and characterisation of long noncoding RNAs
B Signal, BS Gloss, ME Dinger
Trends in Genetics 32 (10), 620-637, 2016
762016
The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
PM O'Brien, MJ Davies, JP Scurry, AN Smith, CA Barton, MJ Henderson, ...
British journal of cancer 98 (6), 1085-1093, 2008
622008
Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers
BS Gloss, KI Patterson, CA Barton, M Gonzalez, JP Scurry, NF Hacker, ...
Cancer letters 318 (1), 76-85, 2012
582012
Methylation-capture and next-generation sequencing of free circulating DNA from human plasma
K Warton, V Lin, T Navin, NJ Armstrong, W Kaplan, K Ying, B Gloss, ...
BMC genomics 15 (1), 1-13, 2014
532014
Realizing the significance of noncoding functionality in clinical genomics
BS Gloss, ME Dinger
Experimental & molecular medicine 50 (8), 1-8, 2018
522018
Long noncoding RNAs CUPID1 and CUPID2 mediate breast cancer risk at 11q13 by modulating the response to DNA damage
JA Betts, MM Marjaneh, F Al-Ejeh, YC Lim, W Shi, H Sivakumaran, ...
The American Journal of Human Genetics 101 (2), 255-266, 2017
492017
MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome
JA Byrne, S Maleki, JR Hardy, BS Gloss, R Murali, JP Scurry, S Fanayan, ...
BMC cancer 10 (1), 1-11, 2010
462010
ZNF300P1 encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer
B Gloss, K Moran-Jones, V Lin, M Gonzalez, J Scurry, NF Hacker, ...
Molecular cancer 13 (1), 1-10, 2014
402014
Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival
CA Barton, BS Gloss, W Qu, AL Statham, NF Hacker, RL Sutherland, ...
British journal of cancer 102 (1), 87-96, 2010
402010
Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer
K Moran-Jones, BS Gloss, R Murali, DK Chang, EK Colvin, MD Jones, ...
Oncotarget 6 (42), 44551, 2015
332015
Machine learning annotation of human branchpoints
B Signal, BS Gloss, ME Dinger, TR Mercer
Bioinformatics 34 (6), 920-927, 2018
232018
Intergenic disease-associated regions are abundant in novel transcripts
N Bartonicek, MB Clark, XC Quek, JR Torpy, AL Pritchard, JLV Maag, ...
Genome biology 18 (1), 1-16, 2017
222017
Cyclin E2 is the predominant E-cyclin associated with NPAT in breast cancer cells
S Rogers, BS Gloss, CS Lee, CM Sergio, ME Dinger, EA Musgrove, ...
Cell division 10 (1), 1-10, 2015
192015
IL-21 contributes to fatal inflammatory disease in the absence of Foxp3+ T regulatory cells
A Vogelzang, HM McGuire, SM Liu, B Gloss, K Mercado, P Earls, ...
The Journal of Immunology 192 (4), 1404-1414, 2014
182014
The system can't perform the operation now. Try again later.
Articles 1–20